NOVEL BIO-BASED DIOLS FROM SUSTAINABLE RAW MATERIALS, USES THEREOF TO MAKE DIGLYCIDYL ETHERS, AND THEIR COATINGS

Information

  • Patent Application
  • 20220372009
  • Publication Number
    20220372009
  • Date Filed
    July 06, 2020
    3 years ago
  • Date Published
    November 24, 2022
    a year ago
Abstract
The invention relates to diols derived from 5-hydroxymethyl furfural, diformyl furan, or derivatives thereof. The invention further relates to diglycidyl ethers derived from the diols of the invention, curable coating compositions containing the diglycidyl ethers, and objects coated with the curable coating compositions. The invention also relates to composites, composites, adhesives, and films containing the diglycidyl ethers of the invention. The invention also relates to methods of making the diols, diglycidyl ethers, and curable coating compositions.
Description
BACKGROUND

The development of green chemical methods for the synthesis of novel monomers for polymer applications has received intense scrutiny in the past two decades. Furthermore, the use of bio-based feedstocks for monomer synthesis has become important due to the projected depletion of fossil fuels in the near future [Kucherov et al., ACS Sustainable Chemistry & Engineering 2018, 6(7):8064-8092; Isikgor et al., Polymer Chemistry 2015, 6(25):4497-4559; Delidovich et al., Chemical Reviews 2016, 116(3):1540-1599; Mülhaupt et al., Macromolecular Chemistry and Physics 2013, 214(2):159-174; Galbis et al., Chemical Reviews 2016, 116(3):1600-1636]. Diols serve as important monomers for the synthesis of a variety of polymers such as polyesters and polyurethanes. Currently, most of the diols used in polymer applications are derived from petroleum.


Of the three important sources of biomass, cellulosic biomass provides access to compounds with a furan skeleton. Two compounds derived from cellulose, 5-hydroxymethyl furfural (HMF) [Yu et al., Bioresource Technology 2017, 238:716-732; van Putten et al., Chemical Reviews 2013, 113(3):1499-1597] and 2,5-furandicarboxylic acid (FDCA) [Jong et al., Furandicarboxylic Acid (FDCA), A Versatile Building Block for a Very Interesting Class of Polyesters. In Biobased Monomers, Polymers, and Materials, American Chemical Society: 2012; Vol. 1105, pp 1-13; Sousa et al., Polymer Chemistry 2015, 6(33):5961-5983], have been identified as the top feedstock compounds for monomer synthesis. HMF has two functional groups at different oxidation states that can be selectively manipulated to provide access to other furan-based monomers. Diformylfuran (DFF) is readily available by selective oxidation of HMF.


The diols are useful monomers in the synthesis of a variety of polymers [Mou et al., ACS Sustainable Chem. Eng. 2016, 4(12):7118-7129]. For example, they are used extensively in the synthesis of polyesters [Li et al., J. Polym. Sci., Part A: Polym. Chem. 2018, 56:968-976]. Also, the glycidyl ethers derived from diols can be cured with diamines to furnish epoxies. The different diols currently used extensively in polymer synthesis are (1) aliphatic diols, (2) bisphenols, and (3) mixed diols. In contrast, the use of diol monomers derived from cellulosic biomass with a furan skeleton has received only limited attention.


SUMMARY OF THE INVENTION

The invention relates to novel diols derived from 5-hydroxymethyl furfural (HMF), diformyl furan (DFF), or derivatives thereof. The invention also relates to the synthesis of the diols.


The invention further relates to diglycidyl ethers derived from the diols of the invention. The invention also relates to the synthesis of the diglycidyl ethers. The invention also relates to composites and adhesives containing the diglycidyl ethers.


The invention further relates to curable coating compositions containing the diglycidyl ethers with amine curing agents, and object coating with the curable coating compositions.







DETAILED DESCRIPTION OF THE INVENTION

The invention relates to a diol having the following structure:




embedded image


wherein R1, R2, R3, and R4 are independently selected from the group consisting of H, C1-C6alkyl, C1-C6 alkenyl, aryl, and C1-C6alkyl-aryl, with the proviso that the diol cannot have the following structure:




embedded image


As used herein, the term “alkyl” refers to a linear, branched, saturated hydrocarbon group, such as methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, tert-butyl, pentyl, hexyl, and the like.


As used herein, the term “alkenyl” refers to a linear, branched hydrocarbon group containing at least one double bond, such as ethenyl, n-propenyl, iso-propenyl, n-butenyl, iso-butenyl, pentenyl, hexenyl, and the like.


As used herein, the term “aryl” refers to an aromatic substituent containing a single aromatic ring or multiple aromatic rings that are fused together, directly linked, or indirectly linked (such that the different aromatic rings are bound to a common group such as a methylene or ethylene moiety). Preferred aryl groups contain 5 to 24 carbon atoms, and particularly preferred aryl groups contain 6 to 10 carbon atoms. Exemplary aryl groups contain one aromatic ring or two fused or linked aromatic rings, e.g., phenyl (Ph), naphthyl, biphenyl, diphenylether, diphenylamine, benzophenone, phenanthryl, and the like.


The diol preferably has the following structure:




embedded image


wherein R1 and R2 are as defined above. Preferably, R1 and R2 are both methyl, ethyl, n-butyl, c-pentyl, allyl, or benzyl.


The diol also preferably has the following structure:




embedded image


wherein R2 is as defined above. Preferably, R2 is n-butyl, t-butyl, c-pentyl, allyl, or benzyl.


The diol also preferably has the following structure:




embedded image


The invention also relates to a method of making the diols of the invention, comprising, consisting essentially of, or consisting of:


reacting 5-hydroxymethyl furfural (HMF), diformyl furan (DFF), or a derivative thereof with a Grignard reagent,

    • under conditions sufficient to form the diol.


Preferably, the Grignard reagent is RMgCl, wherein R is H, C1-C6alkyl, C1-C6alkenyl, aryl, or C1-C6 alkyl-aryl.


Preferably, the derivative used in the method of making the diols of the invention has the following structure:




embedded image


The invention also relates to a diglycidyl ether having the following structure:




embedded image


wherein R1, R2, R3, and R4 are independently selected from the group consisting of H, C1-C6 alkyl, C1-C6 alkenyl, aryl, and C1-C6 alkyl-aryl,


with the proviso that R1, R2, R3, and R4 cannot all be H.


Preferably, the diglycidyl ethers have the following structure:




embedded image


wherein R2 is as defined above. Preferably, R2 is methyl or phenyl.


Preferably, the diglycidyl ethers also have the following structure:




embedded image


wherein R1 and R2 are as defined above. Preferably, R1 and R2 are both methyl, n-butyl, or allyl.


Preferably, the diglycidyl ether also has following structure:




embedded image


The invention also relates to a method for making the diglycidyl ethers of the invention comprising, consisting essentially of, or consisting of:


reacting a diol with epichlorohydrin under conditions sufficient to form the diglycidyl ether,


wherein the diol has the following structure:




embedded image


wherein R1, R2, R3, and R4 are independently selected from the group consisting of H, C1-C6 alkyl, C1-C6 alkenyl, aryl, and C1-C6 alkyl-aryl.


Preferably, the diols used in the methods for making the diglycidyl ethers of the invention cannot have the following structure:




embedded image


The invention also relates to a coating, composite, adhesive, or film comprising, consisting essentially of, or consisting of at least one diglycidyl ether of the invention.


The invention further relates to a curable coating composition comprising, consisting essentially of, or consisting of:


a) at least one diglycidyl ether of the invention; and


b) an amine.


Preferably, the amine is an aliphatic, an aromatic, a cycloaliphatic, or a polyether amine. For example, the aliphatic amine may be Priamine 1075, 1,8-diaminooctane, diethylenetriamine, or tetraethylenepentamine; the aromatic amine may be m-xylylenediamine; the cycloaliphatic amine may be 1,3-bis(aminomethyl)cyclohexane, isophorone diamine, or bis(p-aminocyclohexyl) methane; and the polyether amine may be JEFFAMINE EDR-148 (XTJ-504), JEFFAMINE D-400, JEFFAMINE D-230, or JEFFAMINE T-403.


The curable coating compositions of the invention may be coated onto a substrate and cured using techniques known in the art. The substrate can be any common substrate such as paper, polyester films such as polyethylene and polypropylene, metals such as aluminum and steel, glass, urethane elastomers, primed (painted) substrates, and the like.


Pigments and other additives known in the art to control coating rheology and surface properties can also be incorporated in a curable coating composition of the invention. For example, a curable coating composition of the invention may further contain coating additives. Such coating additives include, but are not limited to, one or more leveling, rheology, and flow control agents such as silicones, fluorocarbons, or cellulosics; extenders; reactive coalescing aids such as those described in U.S. Pat. No. 5,349,026, incorporated herein by reference; plasticizers; flatting agents; pigment wetting and dispersing agents and surfactants; ultraviolet (UV) absorbers; UV light stabilizers; tinting pigments; colorants; defoaming and antifoaming agents; anti-settling, anti-sag and bodying agents; anti-skinning agents; anti-flooding and anti-floating agents; biocides, fungicides and mildewcides; corrosion inhibitors; thickening agents; or coalescing agents. Specific examples of such additives can be found in Raw Materials Index, published by the National Paint & Coatings Association, 1500 Rhode Island Avenue, N.W., Washington, D.C. 20005. Further examples of such additives may be found in U.S. Pat. No. 5,371,148, incorporated herein by reference.


Solvents may also be added to the curable coating formulation in order to reduce the viscosity. Hydrocarbon, ester, ketone, ether, ether-ester, alcohol, or ether-alcohol type solvents may be used individually or in mixtures. Examples of solvents can include, but are not limited to, benzene, toluene, xylene, aromatic 100, aromatic 150, acetone, methylethyl ketone, methyl amyl ketone, butyl acetate, t-butyl acetate, tetrahydrofuran, diethyl ether, ethylethoxy propionate, isopropanol, butanol, butoxyethanol, etc.


The invention further relates to a cured coating composition, wherein the curable coating composition of the invention is cured at ambient conditions or by heating.


The invention also relates to an object coated with the curable coating composition of the invention.


EXAMPLES

Materials


Commercially available HMF was purified by column chromatography or by dissolving it in diethyl ether and drying with anhydrous sodium sulfate and decolorizing with Norrit A. The compound was stored in a freezer prior to use. Diformylfuran (2) was synthesized by oxidation of pure HMF with manganese dioxide and ethyl acetate as a solvent (Scheme 1). The product was recrystallized from iso-propanol before use.




embedded image


Fischer esterification of 2,5-furandicarboxylic acid (FDCA) 3 with ethanol provided the diethyl ester 4 in high yield. The diol, 2,5-bihydroxymethylfuran (5) was synthesized by sodium borohydride reduction of HMF 1 in ethanol (Scheme 2) [Li et al., ACS Sustainable Chem. Eng. 2017, 5(12):11752-11760; Vijjamarri et al., ACS Sustainable Chem. Eng. 2018, 6(2):2491-2497].




embedded image


Synthesis of Symmetric and Unsymmetrical Diols


The formyl group in HMF was converted to a secondary alcohol by the addition of a Grignard reagent. Several variables such as solvent, temperature, stoichiometry and counterion of the Grignard reagent were investigated for obtaining the product diols in high purity and yield. Table 1 lists isolated yields for the unsymmetrical diol 6. The table also lists the physical state of the diol. As can be discerned from the table, the diols are obtained in excellent yield from the Grignard addition. Also, most of the compounds have not been reported previously (References are given for known compounds in Table 1). The product diols were extensively characterized by spectroscopic techniques. The synthesis of diols from HMF is shown Scheme 3 (“R” defined in Table 1).


Typical experimental procedure: A reaction vessel containing solution of purchased Grignard reagent (6.6 mmol, diluted from 1.0-3.4 M to a 0.5 M solution in inhibitor-free drysolv THF) was flushed with N2 and kept under positive N2 pressure. A solution of HMF (3 mmol) dissolved to form a 0.2 M solution in inhibitor-free drysolv THF) was added dropwise via syringe into the dry 50 mL round bottom flask reaction vessel. The reaction was monitored by TLC, until the reaction was complete (1-2 h). To quench the reaction, 6 mL of 0.1 M trisodium citrate (aq) was added via syringe. The reaction mixture was filtered through filter paper, then the THF was removed in vacuo. The resulting oil was then diluted with ethyl acetate (40 mL) and washed with brine (10 mL×3) in a 60 mL reparatory funnel. The organic layer was dried over sodium sulfate, then filtered and solvent removed in vacuo to obtain the product.




embedded image









TABLE 1







Synthesis of unsymmetrical Diols from HMF: Yield and Physical State











En-

Yield




try
R
(%)
State
Reference





1
Methyl (6a)
77
liquid
Finiels, A. et al., Studies in Surface






Science and Catalysis, 135(Zeolites






and Mesoporous Materials at the






Dawn of the 21st Century), 3612-






3619; 2001


2
Ethyl (6b)
91
liquid
Nishimura, Shun; Ebitani, Koki,






Jpn. Kokai Tokkyo Koho (2018),






JP 2018193353 A 20181206.









3
n-Butyl (6c)
94
liquid



4
t-Butyl (6d)
95
liquid



5
c-Pentyl (6e)
78
liquid



6
Allyl (6f)
88
liquid



7
Phenyl (6g)
87
solid
Rajmohan, Rajamani et al.,






RSC Advances, 5(121), 100401-






100407; 2015


8
Benzyl (6h)
80
liquid










HMF Based Diols

Compound 6a: 1H (400 MHz, CDCl3) δ 6.20 (d, J=3.2 Hz, 1H), 6.15 (d, J=3.1 Hz, 1H), 4.83 (q, J=6.6 Hz, 1H), 4.54 (s, 2H), 3.01 (s, 2H), 1.51 (d, 6.6 Hz, 3H); 13C (101 MHz, CDCl3) δ 157.5, 153.3, 108.2, 105.8, 63.3, 57.1, 21.0. FTIR (neat) cm−1 3316, 2979, 2932, 1635, 1557, 1369, 1320, 1239, 1187, 1072. HRMS calculated for C7H10O3Na: 165.0528; Found: 165.0537.


Compound 6b: 1H (400 MHz, CDCl3) δ 6.17 (d, J=3.2 Hz, 1H), 6.13 (d, J=2.8 Hz, 1H), 4.50 (s, 3H), 3.46 (s, 1H), 3.29 (s, 1H), 1.94-1.75 (m, 2H), 0.93 (t, J=7.4 Hz, 3H); 13C (101 MHz, CDCl3) δ 156.5, 153.3, 108.7, 106.5, 69.0, 57.0, 28.3, 10.0. FTIR (neat) cm−1 3304, 2965, 2933, 2876, 1556, 1378, 1318, 1242, 1183, 960. HRMS calculated for C8H12O3Na: 179.0684; Found: 179.0730.


Compound 6c: 1H (400 MHz, CDCl3) δ 6.20 (d, J=3.1 Hz, 1H), 6.15 (d, J=3 Hz, 1H), 4.61 (t, J=6.9 Hz, 1H), 4.53 (s, 2H), 2.93 (s, 1H), 2.82 (s, 1H), 1.83 (dtd, J=8.0, 6.3, 1.2 Hz, 2H), 1.42-1.30 (m, 4H), 0.91 (t, J=7.0 Hz, 3H); 13C (101 MHz, CDCl3) 5156.9, 153.3, 108.2, 106.4, 67.6, 57.2, 35.0, 27.7, 22.4, 14.0. FTIR (neat) cm−1 3315, 2955, 2931, 2861, 1724, 1559, 1457, 1377, 1243, 1182. HRMS calculated for C10H16O3Na: 207.0997; Found: 207.0982.


Compound 6d: 1H (400 MHz, CDCl3) δ 6.24 (d, J=3.1 Hz, 1H), 6.17 (d, J=3.1 Hz, 1H), 4.57 (s, 2H), 4.35 (s, 1H), 2.25 (s, 2H), 0.98 (s, 9H); 13C (101 MHz, CDCl3) δ 155.7, 152.8, 108.2, 107.8, 76.4, 57.4, 35.7, 25.8. FTIR (neat) cm−1 3396, 2955, 2870, 1723, 1552, 1479, 1464, 1394, 1364, 1197. HRMS calculated for C10H16O3Na: 207.0997; Found: 207.0997


Compound 6e: 1H (400 MHz, CDCl3) δ 6.19 (d, J=3.1 Hz, 1H), 6.15 (d, J=3.1 Hz, 1H), 4.53 (s, 2H), 4.37 (d, J=8.6 Hz, 1H), 2.85 (s, 1H), 2.74 (s, 1H), 2.37 (q, J=8.1 Hz, 1H), 1.90-1.84 (m, 1H), 1.66-1.47 (m, 6H), 1.25-1.18 (m, 1H); 13C (101 MHz, CDCl3) δ 156.7, 153.2, 108.2, 106.9, 71.8, 57.3, 44.4, 29.2, 25.5. FTIR (neat) cm−1 3327, 2949, 2867, 1704, 1559, 1449, 1362, 1311, 1885, 931. HRMS calculated for C11H16O3Na: 219.0997; Found: 219.0999.


Compound 6f: 1H (400 MHz, CDCl3) δ 6.19 (d, J=3.2 Hz, 1H), 6.16 (d, J=3.2 Hz, 1H), 5.80 (td, J=17.2, 7.0 Hz, 1H), 5.18-5.11 (m, 2H), 4.67 (t, J=6.5 Hz, 1H), 4.51 (s, 2H), 3.26 (s, 1H), 3.20 (s, 1H), 2.59 (t, J=7.2 Hz, 2H); 13C (101 MHz, CDCl3) 5156.0, 153.4, 133.8, 118.3, 108.3, 106.8, 66.9, 57.2, 39.8. FTIR (neat) cm−1 3320, 2923, 1641, 1557, 1416, 1316, 1182, 916, 860, 793. HRMS calculated for C9H12O3Na: 191.0684; Found: 191.0721.


Compound 6g: 1H NMR (400 MHz, DMSO-d6) δ 7.41 (dd, J=8.3, 1.3 Hz, 2H), 7.37-7.32 (m, 2H), 7.30-7.24 (m, 1H), 6.18 (d, J=3.1 Hz, 1H), 6.04 (d, J=3.1 Hz, 1H), 5.96 (d, J=5.0 Hz, 1H), 5.65 (d, J=5.0 Hz, 1H), 5.15 (t, J=5.7 Hz, 1H), 4.33 (d, J=5.7 Hz, 2H); 13C NMR (101 MHz, DMSO-d6) δ 157.1, 155.1, 143.1, 128.4, 127.6, 127.0, 107.8, 107.3, 68.9, 56.1. FTIR (neat) cm−1 3242, 2881, 1601, 1555, 1491, 1452, 1291, 1263, 1193, 1008. HRMS calculated for C12H12O3Na: 227.0684; Found: 227.0686.


Compound 6h: 1H NMR (400 MHz, CDCl3) δ 7.31-7.17 (m, 5H), 6.17 (d, J=3.1 Hz, 1H), 6.12 (d, J=3.1 Hz, 1H), 4.84 (dd, J=7.9, 5.9 Hz, 1H), 4.51 (s, 2H), 3.31 (s, 1H), 3.13 (qd, J=13.7, 6.9 Hz, 2H), 2.76 (s, 1H); 13C NMR (101 MHz, CDCl3) δ 155.7, 153.4, 137.5, 129.4, 128.4, 126.6, 108.4, 107.1, 68.6, 57.2, 42.0. FTIR (neat) cm−1 3379, 3027, 2922, 1702, 1602, 1495, 1453, 1416, 1360, 1221. HRMS calculated for C13H14O3Na: 241.0841; Found: 241.0839.


Reaction of DFF 2 with excess Grignard reagent gave access to diols 7 (Scheme 4) (“R” defined in Table 2). Table 2 lists the isolated yield of the symmetric diols. As can be seen from the table, the diols are produced in high yields and all of them are liquids. Another noteworthy feature of the diols is that most of them are new compounds. The diols are produced as a mixture of meso and DL products. The products were extensively characterized by spectroscopic techniques. No attempt was made to ascribe chemical shifts to meso and DL products.


Typical experimental procedure: A reaction vessel containing solution of purchased Grignard reagent (6.6 mmol, diluted from 1.0-3.4 M to a 0.5 M solution in inhibitor-free drysolv THF) was flushed with N2 and kept under positive N2 pressure. A solution of DFF (3 mmol) dissolved to form a 0.2 M solution in inhibitor-free drysolv THF) was added dropwise via syringe into the dry 50 mL round bottom flask reaction vessel. The reaction was monitored by TLC, until the reaction was complete (1-2 h). To quench the reaction, 6 mL of 0.1 M trisodium citrate (aq) was added via syringe. The reaction mixture was filtered through filter paper, then the THF was removed in vacuo. The resulting oil was then diluted with ethyl acetate (40 mL) and washed with brine (10 mL×3) in a 60 mL reparatory funnel. The organic layer was dried over sodium sulfate, then filtered and solvent removed in vacuo to obtain the product.




embedded image









TABLE 2







Synthesis of symmetrical diols from DFF: Yield and Physical State











Entry
R
Yield (%)
State
Reference





1
Methyl (7a)
98
liquid



2
Ethyl (7b)
95
liquid



3
n-Butyl (7c)
90
liquid



4
t-Butyl (7d)
94
liquid
Fuentes, Jose A. et al.,






Chemistry Central






Journal (2012), 6,151.


5
c-Pentyl (7e)
95
liquid



6
Allyl (7f)
80
liquid



7
Benzyl (7g)
83
liquid










DFF-Based Diols

Compound 7a: 1H (400 MHz, CDCl3) δ 6.15 (d, J=1.3 Hz, 2H), 4.84 (q, J=6.6 Hz, 2H), 2.79 (s, 2H), 1.52 (d, J=6.6 Hz, 6H); 13C (101 MHz, CDCl3) δ 156.9, 105.6, 63.5, 21.0. FTIR (neat) cm−1 3391, 2980, 2934, 1764, 1702, 1446, 1370, 1302, 1238, 1192. HRMS calculated for C8H12O3Na: 179.0684; Found: 179.0713.


Compound 7b: 1H (400 MHz, CDCl3) δ 6.13 (s, 2H), 4.51 (t, J=6.8 Hz, 2H), 2.94 (s, 2H), 1.86-1.79 (h, 7.2 Hz, 4H), 0.93 (t, J=7.4 Hz, 6H); 13C (101 MHz, CDCl3) δ 195.9, 106.3, 69.0, 28.4, 9.9. FTIR (neat) cm−1 3316, 2964, 2934, 2876, 1557, 1456, 1377, 1315, 1187, 1094. HRMS calculated for C10H16O3Na: 207.0997; Found: 207.1007.


Compound 7c: 1H (400 MHz, CDCl3) δ 6.19 (d, J=3.1 Hz, 1H), 6.14 (d, J=3.1 Hz, 1H), 4.60 (t, J=6.9 Hz, 2H), 2.96 (s, 2H), 1.83 (q, J=7.4 Hz, 4H), 1.44-1.29 (m, 8H), 0.91 (t, J=7.0 Hz, 6H); 13C (101 MHz, CDCl3) δ 156.0, 106.1, 67.4, 36.9, 27.7, 22.4, 13.9. FTIR (neat) cm−1 3337, 2955, 2930, 2860, 1725, 1557, 1457, 1376, 1242, 1104. HRMS calculated for C14H24O3Na: 263.1623; Found: 263.1639.


Compound 7d: 1H NMR (400 MHz, CDCl3) δ 6.19 (s, 1H), 6.17 (s, 1H), 4.36 (s, 1H), 4.34 (s, 1H), 2.49 (s, 2H), 0.97 (m, 18H); 13C NMR (101 MHz, CDCl3) δ 154.6, 107.5, 76.4, 35.7, 25.8. FTIR (neat) cm−1 3429, 3101, 2956, 2871, 1561, 1513, 1413, 1365, 1241, 1189. HRMS calculated for C14H24O3Na: 263.1623; Found: 263.1628.


Compound 7e: 1H (400 MHz, CDCl3) δ 6.20 (d, J=3.1 Hz, 1H), 6.15 (d, J=3.1 Hz, 1H), 4.53 (s, 1H), 4.37 (d, J=8.7 Hz, 1H), 2.86 (s, 1H), 2.72 (s, 1H), 2.37 (q, J=8.2 Hz, 2H), 1.91-1.85 (m, 2H), 1.65-1.47 (m, 12H), 1.25-1.19 (m, 2H); 13C (101 MHz, CDCl3) δ 156.6, 153.2, 108.2, 106.9, 71.8, 57.3, 44.4, 29.3, 29.2, 25.6, 25.5. FTIR (neat) cm−1 3332, 2951, 2867, 1710, 1650, 1450, 1187, 1011, 794, 622. HRMS calculated for C16H24O3Na: 287.1623; Found: 287.1623.


Compound 7f: 1H (400 MHz, CDCl3) δ 6.20 (s, 2H), 5.88-5.76 (m, 2H), 5.21 (q, 1.8 Hz, 2H), 5.17 (m, 1H), 5.14 (m, 1Hf), 4.73 (t, J=5.9 Hz, 3H), 2.62 (m, 3H), 2.39 (s, 2H); 13C (101 MHz, CDCl3) δ 155.4, 133.8, 118.3, 106.6, 66.9, 39.9. FTIR (neat) cm−1 3309, 3076, 2914, 1640, 1431, 1310, 1186, 859, 794, 643. HRMS calculated for C12H16O3Na: 231.0997; Found: 231.1004.


Compound 7g: 1H NMR (400 MHz, CDCl3) δ 7.39-7.20 (m, 10H), 6.15 (d, J=3.1 Hz, 2H), 4.91 (ddd, J=8.0, 5.6, 3.8 Hz, 2H), 3.20-3.10 (s, 4H), 1.91 (s, 2H); 13C NMR (101 MHz, CDCl3) δ 155.2, 137.3, 129.4, 128.5, 126.7, 107.1, 68.7, 42.1. FTIR (neat) cm−1 3346, 2955, 2905, 2869, 1682, 1557, 1479, 1462, 1389, 1365. HRMS calculated for C20H20O3Na: 331.1310; Found: 331.1311.


Synthesis of Glycidyl Ethers


The formation of glycidyl ethers began by synthesizing a known compound as shown in Scheme 5. Treatment of bishydroxymethylfuran 5 with epichlorohydrin, 50% NaOH, tetra n-butylammonium bromide (TBABr, catalyst) at 50° C. gave the diglycidyl ether 8 in 85% isolated yield. The physical and spectral characteristics of 8 were in complete agreement with those reported in the literature [Shen et al., Ind. Eng. Chem. Res. 2017, 56(38):10929-10938; Ding et al., ACS Sustainable Chem. Eng. 2017, 5(9):7792-7799; Hu et al., Macromolecules 2014, 47(10):3332-3342].


Typical experimental procedure:




embedded image


Compound 8: 1H NMR (400 MHz, CDCl3) δ 6.31 (s, 2H), 4.58-4.43 (m, 4H), 3.78 (dd, J=11.5, 3.1 Hz, 2H), 3.46 (dd, J=11.5, 5.9 Hz, 2H), 3.17 (ddt, J=5.8, 4.1, 2.9 Hz, 2H), 2.81 (dd, J=5.0, 4.2 Hz, 2H), 2.63 (dd, J=5.0, 2.7 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 151.8, 110.3, 70.7, 65.1, 50.7, 44.3; FTIR (neat) cm−1 2930, 2871, 1734, 1636, 1457, 1373, 1243, 1090, 929, 855.


After establishing reaction conditions for glycidation, the synthesis of diglycidyl ethers of unsymmetrical diols 6 was undertaken (Scheme 6) (“R” defined in Table 3). The goal was to prepare a diverse set of diglycidyl ethers and evaluate them in epoxy formation using different diamines. The reaction with diol 6 was optimized to obtain the diglycidyl ether 9 in high yield (Table 3). The products were characterized by spectroscopy. The NMR spectra of the products were complex because of the presence of multiple chiral centers. Two different sources for epichlorohydrin were evaluated. A 100% biobased epichlorohydrin gave diglycidyl ethers with a better impurity profile.


Typical experimental procedure: A 50 mL round bottom flask reaction vessel under N2, containing 50 w/v % NaOH, aq. (4.0 g in 4 mL DI H2O), tetrabutylammonium bromide (32.2 mg, 0.1 mmol) and epichlorohydrin (20 mL) was placed in a 50° C. water bath. Before stirring and placing reaction vessel into hot oil bath, a solution of diol (1 mmol) in epichlorohydrin (10 mL) was added to the reaction vessel dropwise. The vessel was lowered into the hot oil bath (50° C.) and stirring started. The reaction was monitored via TLC, and upon completion (2-14 h), the hot reaction mixture was poured over ice. The resulting liquid was transferred to a 125 mL reparatory funnel and diluted with ethyl acetate (40 mL). Then the aqueous layer was removed and the organic layer was washed with brine (20 mL×3). The organic layer was dried over magnesium sulfate, filtered through filter paper, and then the organic solvent was removed in vacuo to obtain the diglycidyl ether.




embedded image









TABLE 3







Diglycidyl ethers derived from unsymmetrical diols 6









ENTRY
R
YIELD (%)





1
Methyl (9a)
92


2
Phenyl (9b)
80









HMF-Based Diglycidyl Ethers

Compound 9a: 1H NMR (400 MHz, CDCl3) δ 6.28 (d, J=3.0 Hz, 1H), 6.23 (d, J=3.2 Hz, 1H), 4.56-4.43 (m, 3H), 3.76 (dd, J=12.3, 3.1 Hz, 1H), 3.65 (ddd, J=20.7, 11.4, 3.3 Hz, 1H), 3.48-3.29 (m, 2H), 3.15 (dq, J=6.0, 3.0 Hz, 1H), 3.10 (dq, J=7.6, 3.9, 3.3 Hz, 1H), 2.80-2.75 (m, 2H), 2.63-2.52 (m, 2H), 1.52 (dd, J=8.6, 6.6 Hz, 3H); BC NMR (101 MHz, CDCl3) δ 155.7, 155.5, 151.1, 151.0, 110.1, 110.0, 107.9, 107.7, 71.1, 71.0, 70.6, 69.5, 68.6, 65.1, 50.9, 50.7, 44.6, 44.4, 44.2, 19.7, 19.5; 13C-DEPT-135 (101 MHz, CDCl3) δ 110.0 (CH2), 107.9 (CH2), 107.7 (CH2), 71.1 (CH2), 71.0 (CH/CH3), 69.5 (CH/CH3), 68.6 (CH/CH3), 65.1 (CH/CH3), 50.7 (CH2), 44.6 (CH/CH3), 44.4 (CH/CH3), 44.2 (CH/CH3), 19.7 (CH2), 19.7 (CH2); 1H—13C HSQC (400 MHz/101 MHz, CDCl13) δ (6.28, 110.1), (6.23, 107.8), (4.54, 71.1), (4.50, 65.1), (3.77, 70.6), (3.68, 69.5), (3.44, 70.6), (3.33, 69.5), (3.15, 50.7), (2.78, 44.3), (2.62, 44.3), (2.54, 44.4), (1.52, 19.7). FTIR (neat) cm−1 2986, 2867, 1711, 1443, 1372, 1322, 1252, 1090, 1013, 911. HRMS calculated for C13H18O5Na: 277.1052; Found: 277.1062.


Compound 9b: 1H NMR (400 MHz, CDCl3) δ 7.45-7.29 (m, 5H), 6.26 (d, J=3.1 Hz, 1H), 6.11-6.06 (m, 1H), 5.48 (d, J=2.8 Hz, 1H), 4.54-4.44 (m, 2H), 3.75 (ddd, J=18.9, 11.4, 3.2 Hz, 2H), 3.58-3.38 (m, 2H), 3.22-3.11 (m, 2H), 2.80-2.75 (m, 2H), 2.62-2.56 (m, 2H); 13C NMR (101 MHz, CDCl3) δ 154.6, 154.5, 151.6, 138.7, 138.6, 128.4, 128.1, 128.1, 127.3, 127.1, 110.2, 109.5, 109.3, 77.5, 70.5, 69.8, 69.5, 65.1, 50.8, 50.6, 44.4; 13C-DEPT-135 (101 MHz, CDCl3) δ 128.4 (CH/CH3), 127.3 (CH/CH3), 127.1 (CH/CH3), 110.2 (CH/CH3), 109.5 (CH/CH3), 109.3 (CH/CH3), 77.5 (CH/CH3), 70.5 (CH2), 69.8 (CH2), 69.56 (CH2), 65.1 (CH2), 50.7 (CH/CH3), 50.6 (CH/CH3), 44.4 (CH2); 1H—13C HSQC (400 MHz/101 MHz, CDCl3) δ (7.44, 127.2), (7.37, 128.2), (6.27, 110.2), (6.09, 109.5), (5.48, 77.5), (4.49, 65.1), (3.76, 69.6), (3.74, 70.5), (3.62, 69.8), (3.55, 70.5), (3.48, 69.6), (3.42, 70.5), (3.20, 50.7), (3.13, 50.6), (2.77, 44.4), (2.59, 44.3). FTIR (neat) cm−1 2998, 2921, 1555, 1494, 1452, 1334, 1252, 1060, 1021, 845. HRMS calculated for C18H20O5Na: 339.1208; Found: 339.1208.


The diglycidyl ethers of symmetrical diols 7 were also synthesized (Scheme 7) (“R” defined in Table 4). The reactions were slightly less efficient as compared to reactions with unsymmetrical diols (Table 4). The products were fully characterized by spectroscopy.




embedded image









TABLE 4







Diglycidyl ethers derived from symmetrical diols 7









ENTRY
R
YIELD (%)





1
Methyl (10a)
65


2
Allyl (10b)
74


3
n-Butyl (10c)
82









DFF-Based Diglycidyl Ethers

Compound 10a: 1H NMR (400 MHz, CDCl3) δ 6.22 (s, 2H), 4.54 (p, J=6.5 Hz, 2H), 3.64 (ddd, J=16.4, 11.4, 3.3 Hz, 2H), 3.54-3.30 (m, 2H), 3.15-3.06 (m, 1H), 2.84-2.74 (m, 2H), 2.63 (dd, J=4.8, 2.8 Hz, 2H), 2.59-2.51 (m, 1H), 1.59-1.46 (t, 1=6.6 Hz, 6H); 13C-DEPT-135 (101 MHz, CDCl3) δ 155.0, 107.6, 71.1, 69.5, 68.6, 50.9, 44.4, 19.4; FTIR (neat) cm−1 3061, 2985, 2928, 2864, 1446, 1372, 1253, 1089, 913, 851. HRMS calculated for C14H20O5Na: 291.1208; found:


Compound 10b: 1H NMR (400 MHz, CDCl3) δ 6.25 (q, J=1.6 Hz, 2H), 5.76 (dqd, J=17.2, 6.9, 3.5 Hz, 2H), 5.18-4.96 (m, 4H), 4.48-4.34 (m, 2H), 3.72-3.55 (m, 2H), 3.47 (dt, J=11.5, 4.4 Hz, 1H), 3.32 (ddd, J=11.4, 6.1, 2.4 Hz, 1H), 3.11 (tt, J=8.5, 4.8 Hz, 1H), 2.78 (q, J=4.7 Hz, 2H), 2.75-2.49 (m, 6H); 13C NMR (101 MHz, CDCl3) δ 153.7, 133.8, 117.4, 108.8, 108.6, 75.1, 75.0, 69.6, 68.8, 50.8, 50.6, 44.6, 44.3, 38.5; 13C-DEPT-135 (101 MHz, CDCl3) δ 133.9 (CH2), 117.4 (CH/CH3), 108.9 (CH2), 108.6 (CH2), 75.2 (CH2), 74.9 (CH2), 69.6 (CH/CH3), 68.7 (CH/CH3), 50.9 (CH2), 50.6 (CH2), 44.6 (CH/CH3), 44.3 (CH/CH3), 38.5 (CH/CH3); 1H—13C HSQC (400 MHz/101 MHz, CDCl13) δ (6.25, 108.8), (5.76, 133.7), (5.12, 117.3), (5.06, 117.3), (4.40, 75.0), (3.71, 69.5), (3.59, 68.8), (3.48, 68.7), (3.33, 69.5), (3.10, 50.8), (2.79, 44.5), (2.68, 38.5), (2.64, 44.5), (2.53, 44.3). FTIR (neat) cm−1 3074, 2998, 2918, 1641, 1431, 1316, 1252, 1160, 1190, 992. HRMS calculated for C18H24O5Na: 343.1521; found: 343.1519.


Compound 10c: 1H NMR (400 MHz, CDCl3) δ 6.21 (t, J=1.8 Hz, 2H), 4.31 (dt, J=13.8, 7.0 Hz, 2H), 3.65-3.50 (m, 2H), 3.48-3.35 (m, 2H), 3.29 (ddt, J=11.4, 6.1, 1.8 Hz, 2H), 3.08 (tq, J=7.9, 3.8 Hz, 2H), 2.75 (q, J=4.9 Hz, 2H), 2.60 (dd, J=5.1, 2.7 Hz, 2H), 2.50 (dt, J=5.1, 2.7 Hz, 4H), 1.97-1.72 (m, 4H), 1.44-1.10 (m, 6H), 0.87 (t, J=7.1 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 154.2, 108.3, 75.4, 69.5, 68.7, 50.9, 50.6, 44.6, 44.3, 33.7, 27.7, 22.4, 13.9; 13C-DEPT-135 (101 MHz, CDCl3) δ 108.5 (CH/CH3), 75.7 (CH/CH3), 69.5 (CH2), 68.7 (CH2), 50.9 (CH/CH3), 50.6 (CH/CH3), 44.6 (CH2), 44.3 (CH2), 33.7 (CH2), 27.7 (CH2), 22.44 (CH2), 13.9 (CH/CH3); 1H—13C HSQC (400 MHz/101 MHz, CDCl13) δ (6.21, 108.0), (4.32, 75.5), (3.62, 69.5), (3.54, 68.7), (3.45, 68.7), (3.29, 69.5), (3.07, 50.8), (2.75, 44.5), (2.60, 44.6), (2.50, 44.3), (1.89, 33.7), (1.82, 33.7), (1.34, 27.7), (1.33, 22.4), (1.21, 27.6), (0.88, 14.0). FTIR (neat) cm−1 2955, 2930, 2861, 1466, 1379, 1320, 1253, 1090, 1013, 795. HRMS calculated for C20H32O5Na: 375.2147; found: 375.2146.


A tertiary diol 11 was synthesized from by the addition of excess methylmagnesium chloride to FDCA diethyl ester 4 in 85% yield (Scheme 7). The solid diol was not stable and underwent dehydration readily. However, the compound could be stored in a freezer without decomposition.




embedded image


Procedure: A reaction vessel containing solution of purchased Grignard reagent (13.5 mmol eq, diluted from 1.0-3.4 M to a 0.5 M solution in inhibitor-free drysolv THF) was flushed with N2 and kept under positive N2 pressure. A solution of substrate (3 mmol, dissolved to form a 0.1 M solution in inhibitor-free drysolv THF) was added dropwise via syringe into the dry 50 mL round bottom flask reaction vessel. The reaction was monitored by TLC, until the reaction was complete (1-2 h). To quench the reaction, 6 mL of 0.1 M trisodium citrate (aq) was added via syringe. The reaction mixture was filtered through filter paper, then the THF was removed in vacuo. The resulting oil was then diluted with ethyl acetate (40 mL) and washed with brine (10 mL×3) in a 60 mL reparatory funnel. The organic layer was dried over sodium sulfate, then filtered, and solvent removed in vacuo to obtain the diol product in 85% yield.


Compound 11: 1H (400 MHz, CDCl3) δ 6.09 (s, 2H), 2.49 (s, 2H), 1.58 (s, 12H); 13C (101 MHz, CDCl3) δ 159.0, 104.0, 68.7, 28.5. FTIR (neat) cm−1 3362, 2979, 2900, 1375, 1267, 1164, 1115, 1022, 959, 840. HRMS calculated for C10H16O3Na: 207.0997; Found: 207.0994.


The glycidation of 11 to provide diglycidyl ether 12 was successful and gave the product in 75% yield (Scheme 8). It is interesting to note highly hindered ether such as 12 could be accessed. However, the glycidation was slow as compared to reactions with less hindered alcohols.




embedded image


Compound 12: 1H NMR (400 MHz, CDCl3) δ 6.17 (d, J=3.2 Hz, 1H), 6.12 (d, J=3.2 Hz, 1H), 3.37 (dd, J=11.0, 3.7 Hz, 2H), 3.22 (dd, J=11.0, 5.5 Hz, 2H), 3.06-2.99 (m, 2H), 2.75 (t, 5 Hz, 2H), 2.53 (dd, J=5.1, 2.7 Hz, 2H), 1.59 (s, 6H), 1.56 (s, 6H); 13C NMR (101 MHz, CDCl3) δ 159.87, 155.8, 107.5, 103.7, 73.3, 68.7, 64.4, 51.0, 44.9, 28.5, 25.7. FTIR (neat) cm−1 2968, 2905, 1375, 1350, 1252, 1168, 1112, 1018, 963, 837. HRMS calculated for C16H24O5Na: 319.1521; found: 319.1513.


Reaction of Diglycidyl Ethers with Diamines


To evaluate the curing ability of the diglycidyl ether bis-epoxymonomers with four different types of amine curatives, high throughput and conventional methods were used to extract maximum property information of the crosslinked networks with minimal material in a short period of time. The properties of the networks formed from the novel diglycidyl ether bis-epoxymonomers as a function of curative type, cure temperature, and time of curing are disclosed. For comparison, commercial BPA based epoxy resin EPON 828 (Momentive) was used as reference. To evaluate the relative crosslink density of the crosslink networks high throughput dye extraction and nano-indentation technique were used. Conventional methods such as König pendulum hardness and differential scanning calorimetry (DSC) were used to further evaluate the crosslinked networks.


1.1. Materials


The materials used are described in Table 5.









TABLE 5







Starting materials









Chemical
Designation
Vendor





Bisphenol A diglycidyl ether
EPON 828
Momentive


Perylene, 98+%
Perylene
Alfa Aesar


Toluene
Toluene
BDH Chemicals


Methyl ethyl ketone, 99%
MEK
Alfa Aesar


Perylene, 98+%,
Perylene
Alfa Aesar


Aluminum panels 4″ × 8″
Aluminum panels
Q-LAB


polypropylene microtiter plates

Evergreen Scientific.









1.2. Preparation of Formulations


Formulations from the diglycidyl ether bis-epoxymonomers and EPON 828 were prepared with four types of amine curatives (total twelve amine curatives listed in Table 6) to investigate the reactivity of the diglycidyl ether bis-epoxymonomers towards different amine curatives and simultaneously the impact of the nature of amine curative on the properties of the cured coatings. To evaluate the relative performance of curatives towards crosslinking, the dye extraction method previously reported by Bach et al. [Bach et al., Farbe Lack 2002, 108:30; 2. Bach et al., in High-Throughput Analysis: A Tool for Combinatorial Materials Science, eds. R. A. Potyrailo and E. J. Amis, Springer US, Boston, Mass., 2003, pp. 525-549.] was used. Prior to making formulations, a 3 mM solution of perylene dye in toluene was prepared. A representative procedure for making dye incorporated formulation of EPON 828 with isophorone diamine as curative is as follows: 1.14 g of EPON 828 resin was transferred into a 20 mL glass vial, where, 2.56 mL of methyl ethyl ketone (MEK) solvent and 202 μL of perylene dye solution were subsequently added and mixed using Teflon coated magnetic stir bar at 900 rpm on multi-position magnetic stirring plates for 25 min. Next, 0.26 g of isophorone diamine (Epoxy to amine ratio was 1:1) was added to the mixture and mixed for another 20 min prior to deposition on primed aluminum discs. For all the formulations and the amount of dye per formulation unit volume was kept constant.









TABLE 6







List of amine curatives used to study properties of crosslinked networks.














Amine hydrogen






equivalent



Type
Name of curative
Designation
weight (AHEW)
Vendors














Aliphatic
Priamine 1075
Priamine
267
Croda



1,8-Diaminooctane
1,8-DA Octane
36.07
Sigma Aldrich



Diethylenetriamine
DETAA
20.63
Sigma Aldrich



Tetraethylenepentamine
TEPAA
24.37
Sigma Aldrich


Aromatic
m-Xylylenediamine
Xylene DA
34.05
Sigma Aldrich


Cyclo-
1,3-
1,3 BAC
35.55
Mitsubishi


aliphatic
Bis(Aminomethyl)cyclohexane


gas






chemicals



Isophorone diamine
IPDA
42.68




bis(p-aminocyclohexyl)
PACM
52.5
Sigma Aldrich



methane





Polyether
JEFFAMINE EDR-148 (XTJ-504)
XTJ-504
37.05
Huntsman






Corporation



JEFFAMINE D-400
Jeff. D-400
115
Huntsman






Corporation



JEFFAMINE D-230
Jeff. D-230
60
Huntsman






Corporation



JEFFAMINE T-403
Jeff, t-403
81
Huntsman






Corporation









2. Methods and Instruments


2.1. Dye Extraction


Preparation for the dye extraction method was carried out by punching out 10 mm epoxy primed aluminum discs and affixing them to a 4″×8″ aluminum panel in a 6×11 array format. 75 μL of each formulation was deposited on six discs using an Eppendorf repeat pipettor. Coatings were then allowed to dry overnight under ambient conditions. Array panels were then cured at room temperature for 7 days, 60° C. and 100° C. using preheated oven for 1 h., 3 h., or 6 h. to evaluate the optimum curing condition. After curing, three discs from each set (same formulation and curing regime) were transferred into 24 well (6×4) polypropylene microtiter plates, each row of wells containing two sets of discs. The discs were affixed to the bottom of each well with double-sided tape and were allowed to adhere for 18+ hours prior to dye extraction.


Dye extraction was performed by adding 500 μL of toluene to each well of the microtiter plate using an Eppendorf repeat pipettor. Toluene was quickly added to each row of the microtiter plate with 15 s intervals between the rows. Formulations were allowed to soak for 10 min on an orbital shaker, then 150 uL of each extraction sample was collected and transferred to a 96 well microtiter plate using a 6-channel, adjustable spacing, multichannel pipette. Each row of two sets with three replicates was collected at the same time, aspirating twice to ensure a homogenous mixture. The timing of collection for each individual formulation was held to 15 second intervals to ensure that the soaking time was precise. Fluorescence measurements (415ex/471em) of all extraction samples using a TECAN Saffire2 plate reader were taken immediately following collection.


2.2. Nano-Indentation


Depth sensing indentation, also called instrumented indentation or nanoindentation, was performed using a Hysitron TriboIndenter with automation (9 samples per run) using a diamond Berkovich tip. Since accurate determination of the elastic modulus from the indentation load-displacement responses requires flat sample surfaces, indentation was performed mostly near the center of the coated discs. Before every indent, the indenter was held in contact with the surface, to allow for piezoactuator stabilization (35 s) and drift correction (40 s), at a contact load of only 0.5 mN to prevent any deformation prior to the indentation experiment. The drift rate (typically 0.1 nm s21) was automatically determined over the last 20 s of the 40 s period. After lifting the tip up to 30 nm and re-approaching the surface (surface detection at a load of 0.5 mN), the tip was loaded to maximum load of 300 μN in 5 s, held at maximum load for 5 s and unloaded in 5 s. Nine measurements with a spacing of 60 μm apart were performed per sample and the first one was left out from the analysis to further reduce the influence of drift.


2.3. Differential Scanning Calorimetry


Thermal properties of the cured coatings were characterized using Q1000 Modulated Differential Scanning Calorimeter from TA Instruments with a cooling limit up to −90° C. About 6-8 mg of the cured film was scraped out from the disc and the following heat/cool/heat regime was used: the sample was first equilibrated at 23° C. and then cooled to −10° C. at 10° C./minute, held at −10° C. for 2 min and heated to 100° C. at 10° C./minute.


2.4. König Pendulum Hardness


Kônig pendulum hardness was measured according to ASTM D 4366-16 by sticking two cured coated discs on a steel panel on top of which steel balls of the pendulum were placed; the result was reported in seconds.


2.5. Drying Time Measurement


Drying time was measured according to ASTM D 1640. Due to small size of the coated discs dry-to-touch time was recorded when the coating no longer adheres to the finger and does not rub up appreciably when the finger was lightly rubbed across the surface.


2.5. Measurement of Epoxy Equivalent Weight


Epoxy equivalent weight (EEW, g/eq.) of the diglycidyl ether bis-epoxymonomers and EPON 828 resin were evaluated by titrating epoxy samples with 0.0925 N solution of HBr in glacial acetic acid; 1 wt. % solution of crystal violet in acetic acid was used as an indicator. EEW value was calculated using the following equation (1) and the values are reported in Table 7, where W is the sample mass in grams, N is the normality of HBr solution, and V is the volume of HBr solution used for titration in mL.






EEW
=


100

×
W


N
×
V













TABLE 7







Epoxy equivalent weight (EEW, g/eq.) of the diglycidyl ether bis-epoxymonomers and EPON


828 resin.









Resin

EEW (g/eq)












GLY 13/16


embedded image


165.85





GLY 23/24


embedded image


148.92





GLY 17


embedded image


157.18








GLY 25


embedded image


158.23





EPON 828

190









3. Results


3.1. Drying Time


Drying time was measured as a preliminary study to estimate the reactivity of the novel diglycidyl ether bis-epoxymonomers towards various amine curatives. See Table 8. Drying time of EPON 828 was measured with the curatives as a reference.









TABLE 8







Drying time of diglycidyl ether bis-epoxymonomers and EPON 828 with amine curatives.









Dry-to-touch time (hr.)












Amine Curatives
EPON 828
GLY 23/24
GLY 17
GLY 13/16
GLY 25















TEG-DA (XTJ-504)
16
PS
18
14
NI


Jeffamine t403
13
42
23
24
33


Jeffamine D-230
25
77
24
17
56


Jeffamine D-400
NI
91
28
NI
62


PACM
8
18
22
15
19


1,3-BAC
8
17
20
22
16


IPDA
11
16
22
12
16


Xylene diamine
5
22
28
13.5
20


Diethylenetriamine
6
PS
20
16
17


Tetraethylenepentamine
5
PS
23
18
21


Priamine 1075
PS
PS
PS
PS
PS


1,8 DA Octane
6
17
20
14
15





S-Phase separation


NI-Not included in the study






3.2. Dye Extraction Results


The dye extraction method described previously was used to estimate the relative crosslink density of the coatings. Higher values of dye extraction are related to lower crosslinked coatings and vice versa. The tables below show the dye extraction results for coatings made from the diglycidyl ethers and amine curing agents cured under room temperature (RT) conditions as well as at elevated temperatures for the times shown.









TABLE 9







Dye extraction results of coatings formulated from


GLY 23/24 with amine curatives.










Curing Temperature





(° C.)
RT
60
100














Curing Time
7 Days
1 h.
3 h.
6 h.
1 h.
3 h.
6 h.





TEG-DA (XTJ-504)
20578
20991
20042
20125
16544
15915
14557


Jeffamine t403
16333
14895
14522
16578
14166
13552
15073


Jeffamine D-230
20123
18786
19086
21048
16687
16101
17574


Jeffamine D-400
21019
20998
21705
24856
21326
20358
21549


PACM
11116
10935
10700
13334
10545
9585
10708


1,3-BAC
13703
14280
14332
16715
14072
13036
14344


IPDA
18306
13541
12157
13322
12930
11862
13441


Xylene diamine
15516
12031
11821
12910
13804
13590
14816


Diethylenetriamine
15139
14594
16254
20919
17731
19418
21345


Tetraethylenepentamine
17050
16644
17776
25250
22196
19136
13935


Priamine 1075
24208
20580
20400
22766
19842
18530
19752


1,8 DA Octane
12018
 6414
 5302
 5205
 7972
 8954
 7946
















TABLE 10







Dye extraction results of coatings formulated


from GLY 13/16 with amine curatives.










Curing Temperature





(° C.)
RT
60
100














Curing Time
7 Days
1 h.
3 h.
6 h.
1 h.
3 h.
6 h.

















TEG-DA (XTJ-504)
204
214
152
129
168
124
142


Jeff. t403
3463
3611
3519
2492
2858
2473
1665


Jeff. D-230
8819
9187
9554
9955
8043
7003
7356








Jeff. D-400
NI














PACM
304
1525
760
126
213
61
107


1,3-BAC
1376
324
250
426
679
234
124


IPDA
127
136
84
54
127
103
77


Xylene diamine
174
72
92
100
170
120
91


DETA
341
105
111
105
76
81
78


TEPA
703
126
748
148
548
166
525


Priamine 1075
44637
45440
46136
48543
37621
33993
30476


1,8 DA Octane
272
608
529
326
693
196
152





NI—Not included in the study













TABLE 11







Dye extraction results of coatings formulated


from GLY 17 with amine curatives.










Curing Temperature





(° C.)
RT
60
100














Curing Time
7 Days
1 h.
3 h.
6 h.
1 h.
3 h.
6 h.

















TEG-DA (XTJ-504)
738
2114
2604
3033
4141
3087
2258


Jeffamine t403
3720
3663
3703
2608
3016
2542
2072


Jeffamine D-230
27621
28338
28333
27862
23012
18084
13276


Jeffamine D-400
38468
40511
40735
40689
36651
32086
30629


PACM
3500
2994
2906
641
1145
286
130


1,3-BAC
2321
2042
790
163
6012
5233
4326


IPDA
2863
6772
7299
702
1885
203
116


Xylene diamine
7401
1100
1100
956
15431
23468
13669


Diethylenetriamine
931
1121
1409
678
1363
309
342


Tetraethylenepentamine
29781
25886
25229
27807
3889
1879
1293


Priamine 1075
44422
44165
44577
45501
40452
38352
35642


1,8 DA Octane
20532
12378
10432
8193
6087
6035
6005
















TABLE 12







Dye extraction results of coatings formulated


from GLY 25 with amine curatives.










Curing Temperature





(° C.)
RT
60
100














Curing Time
7 Days
1 h.
3 h.
6 h.
1 h.
3 h.
6 h.











TEG-DA (XTJ-504)
NI














Jeffamine t403
17277
16437
17283
15196
15751
15142
13292


Jeffamine D-230
12654
13080
14141
13358
9596
10105
10171


Jeffamine D-400
34037
35898
35054
36861
31008
28581
28691


PACM
3493
9923
7238
6320
11110
9384
7539


1,3-BAC
13117
13626
13394
11472
8623
2590
1397


IPDA
15948
15468
15904
15007
13542
11417
11280


Xylene diamine
2167
2264
2782
1396
7190
4469
2173


Diethylenetriamine
9138
5968
6416
5996
1483
1882
607


Tetraethylenepentamine
14755
10584
4889
4971
867
879
820


Priamine 1075
37500
32975
48161
45077
37220
35820
31653


1,8 DA Octane
1124
1811
2098
2595
1704
726
679





NI—Not included in the study













TABLE 13







Dye extraction results of coatings formulated


from EPON 828 with amine curatives.










Curing Temperature





(° C.)
RT
60
100














Curing Time
7 Days
1 h.
3 h.
6 h.
1 h.
3 h.
6 h.

















TEG-DA (XTJ-504)
8648
1153
1124
1358
1124
887
501


Jeffamine t403
568
13751
3867
353
336
64
68


Jeffamine D-230
1327
17265
4245
247
212
115
96


PACM
1107
247
227
211
37
36
35


1,3-BAC
628
1172
917
1331
189
123
108


IPDA
132
426
130
84
44
56
36


Xylene diamine
8704
91
90
84
72
55
42


Diethylenetriamine
11478
7004
5431
3014
1198
885
487


Tetraethylenepentamine
18994
1604
391
643
425
335
338


Priamine 1075
5075
31762
31543
29461
26349
22649
23601


1,8 DA Octane
13289
995
488
157
589
63
63









3.3. Pendulum Hardness Results


Kônig pendulum hardness measurements were carried out on the coatings made by reacting the diglycidyl ethers with the amine curing agents at room temperature (RT) and elevated temperatures for the times indicated. Higher pendulum hardness value indicates a harder coating.









TABLE 14







Pendulum hardness of coatings formulated


from GLY 23/24 with amine curatives.










Curing Temperature





(° C.)
RT
60
100














Curing Time
7 Days
1 h.
3 h.
6 h.
1 h.
3 h.
6 h.











TEG-DA (XTJ-504)
PS, T














Jeffamine t403
27
19
21
25
25
22
24


Jeffamine D-230
16
19
22
20
18
19
21


Jeffamine D-400
31
28
33
43
26
39
53


PACM
29
10
36
33
43
54
61


1,3-BAC
8
5
11
14
7
11
15


IPDA
10
25
91
97
61
66
83


Xylene diamine
12
8
7
9
4
4
5, W








Diethylenetriamine
PS, W


Tetraethylenepentamine



Priamine 1075
PS, T














1,8 DA Octane
17
24
32
19
21
15
19





PS—Phase separated


T—Tacky


W—Wrinkled













TABLE 15







Pendulum hardness results of coatings formulated from GLY 13/16


with amine curatives.










Curing Temperature





(° C.)
RT
60
100














Curing Time
7 Days
1 h.
3 h.
6 h.
1 h.
3 h.
6 h.

















TEG-DA (XTJ-504)
8
7
7
7
11
17
19


Jeffamine t403
75
59
134
143
44
154
153


Jeffamine D-230
10
7
7
9
7
7
11








Jeffamine D-400
NI














PACM
32
163
173
191
173
151
177


1,3-BAC
7
13
20
23
61
95
108


IPDA
185
186
187
195
154
193
200


Xylene diamine
13
12
17
18
17
63
68


Diethylenetriamine
14
12
13
17
26
79
105


Tetraethylenepentamine
28
9
25
36
141
179
183








Priamine 1075
PS














1,8 DA Octane
15
16
18
13
17
22
28





NI—Not included in the study


PS—Phase separated













TABLE 16







Pendulum hardness results of coatings formulated


from GLY 17 with amine curatives.










Curing Temperature





(° C.)
RT
60
100














Curing Time
7 Days
1 h.
3 h.
6 h.
1 h.
3 h.
6 h.

















TEG-DA (XTJ-504)
6
6
7
14
7
13
W


Jeffamine t403
86
66
150
171
85
152
178








Jeffamine D-230
NI


Jeffamine D-400















PACM
44
113
109
116
152
174
176


1,3-BAC
39
38
36
42
71
140
173


IPDA
80
130
140
146
152
192
202


Xylene diamine
9
14
20
30
10
27
88


Diethylenetriamine
4
7
9
9
36
88
134








Tetraethylenepentamine
NI


Priamine 1075
PS, T














1,8 DA Octane
4
11
14
15
13
17
20





NI—Not included in the study


PS—Phase separated


T—Tacky













TABLE 17







Pendulum hardness results of coatings formulated


from GLY 25 with amine curatives.










Curing Temperature





(° C.)
RT
60
100














Curing Time
7 Days
1 h.
3 h.
6 h.
1 h.
3 h.
6 h.











TEG-DA (XTJ-504)
NI














Jeffamine t403
9
11
11
11
9
12
13








Jeffamine D-230
NI


Jeffamine D-400















PACM
30
107
50
27
83
127
169


1,3-BAC
9
25
27
31
42
125
123


IPDA
30
18
17
13
11
9
10


Xylene diamine
7
6
7
38
40
38
45








Diethylenetriamine
NI


Tetraethylenepentamine



Priamine 1075
PS














1,8 DA Octane
158
159
152
157
127
174
169





NI—Not included in the study


PS—Phase separated













TABLE 18







Pendulum hardness of coatings formulated from


EPON 828 with amine curatives.










Curing Temperature





(° C.)
RT
60
100














Curing Time
7 Days
1 h.
3 h.
6 h.
1 h.
3 h.
6 h.

















TEG-DA (XTJ-504)
13
33
22
46
85
93
95


Jeffamine t403
140
135
180
87
147
176
167


Jeffamine D-230
171
195
178
212
139
180
107


PACM
151
107
160
159
155
157
153


1,3-BAC
130
140
138
136
131
135
138


IPDA
133
89
150
175
160
171
166


Xylene diamine
56
49
104
92
118
137
134


Diethylenetriamine
9
35
44
48
78
107
117


Tetraethylenepentamine
32
32
82
71
122
159
121








Priamine 1075
HW


1,8 DA Octane






HW—Highly Wrinkled






3.2. Results from DSC









TABLE 19







Glass transition temperature (Tg) of coatings formulated from GLY 23/24 with amine curatives.












Curing Temperature (° C.)
RT
60
100



Curing Time
7 Days
3 h.
3 h.
















TEG-DA (XTJ-504)
−1
3
5



Jeffamine t403
5
6
7



Jeffamine D-230
−1
−1
12



Jeffamine D-400
−3
0
40



PACM
30
29
32



1,3-BAC
56
21
19



IPDA
25
38
34



Xylene diamine
9
13
20










Diethylenetriamine
PS












Tetraethylenepentamine






Priamine 1075















1,8 DA Octane
13
12
15







PS-Phase separated













TABLE 20







Glass transition temperature (Tg) of coatings formulated from GLY 13/16 with amine curatives.












Curing Temperature (° C.)
RT
60
100



Curing Time
7 Days
3 h.
3 h.
















TEG-DA (XTJ-504)
14
15
17



Jeffamine t403
38
40
60



Jeffamine D-230
11
12
14










Jeffamine D-400
NI












PACM
39
50
63



1,3-BAC
15
22
45



IPDA
41
54
57



Xylene diamine
6
13
42



Diethylenetriamine
16
19
39



Tetraethylenepentamine
32
36
39










Priamine 1075
PS












1,8 DA Octane
7
15
19







PS-Phase separated



NI-Not included in the study













TABLE 21







Glass transition temperature (Tg) of coatings formulated from


GLY 17 with amine curatives.










Curing Temperature





(° C.)
RT
60
100














Curing Time
7 Days
1 h.
3 h.
6 h.
1 h.
3 h.
6 h.

















TEG-DA (XTJ-504)
−6
1
3
6
20
23
27


Jeffamine t403
39
36
39
40
40
41
45








Jeffamine D-230
NI


Jeffamine D-400















PACM
33
31
39
41
39
39
41


1,3-BAC
34
32
39
33
36
42
47


IPDA
−8
41
42
42
42
52
59


Xylene diamine
7
25
30
27
21
26
30


Diethylenetriamine
13
17
19
26
33
37
37








Tetraethylenepentamine
NI


Priamine 1075















1,8 DA Octane
29
8
16
26
26
27
30





NI—Not included in the study













TABLE 22







Glass transition temperature (Tg) of coatings formulated from


GLY 25 with amine curatives.










Curing Temperature





(° C.)
RT
60
100














Curing Time
7 Days
1 h.
3 h.
6 h.
1 h.
3 h.
6 h.











TEG-DA (XTJ-504)
NI














Jeffamine t403
3
3
3
5
3
2
3








Jeffamine D-230
NI


Jeffamine D-400















PACM
14
9
23
28
27
29
33


1,3-BAC
16
15
28
29
25
30
35


IPDA
33
17
20
29
31
33
35


Xylene diamine
17
11
16
35
27
30
31








Diethylenetriamine
NI


Tetraethylenepentamine



Priamine 1075















1,8 DA Octane
−4
−4
4
11
6
11
21





Nl—Not included in the study













TABLE 23







Glass transition temperature (Tg) of coatings formulated from EPON 828 with amine curatives.












Curing Temperature (° C.)
RT
60
100



Curing Time
7 Days
3 h.
3 h.







TEG-DA (XTJ-504)
52
54
54



Jeffamine t403
53
58
63



Jeffamine D-230
47
56
57



Jeffamine D-400
50
49
51



PACM
47
49
51



1,3-BAC
44
46
48



IPDA
48
53
55



Xylene diamine
53
60
61



Diethylenetriamine
53
58
62



Tetraethylenepentamine
23
34
39



Priamine 1075
36
45
54



1,8 DA Octane
52
55
61










3.2. Results from Nano-Indentation









TABLE 24







Hardness (GPa) of coatings formulated from GLY 23/24, GLY 13/16, GLY 17 and EPON


828 with amine curatives.












Curing Temperature (° C.)
RT
60
100















Resin
Curing Time
7 Days
1 hr.
3 hr.
6 hr.
1 hr.
3 hr.
6 hr.












GLY 23/24
TEG-DA (XTJ-504)
PS
















Jeffamine t403
1.94
1.85
2.07
1.57
1.78
1.80
1.39










Jeffamine D-230
S



Jeffamine D-400

















PACM
51.25
2.59
8.26
16.46
35.72
25.55
108.96



1,3-BAC
1.37
1.25
6.72
7.25
1.34
2.54
2.55



IPDA
67.34
5.38
140.12
152.38
46.27
21.76
94.22



Xylene diamine

39.09















Diethylenetriamine
PS



Tetraethylenepentamine




Priamine 1075

















1,8 DA Octane
49.40
12.29
51.43
4.42
2.18
1.95
1.79


GLY 17
Jeffamine t403
222.06
3.71
46.69
260.36
167.28
146.40
268.56


GLY 13/16
Jeffamine t403
223.28
38.88
131.89
274.07
158.80
154.26
286.52



PACM
225.24
299.19
221.63
362.53
244.32
253.11
332.73



1,3-BAC
24.39
13.43
391.02
207.58
273.34
481.07
528.59


EPON 828
TEG-DA (XTJ-504)

130.70
102.86







Jeffamine t403
323.52
204.75
255.74
258.47
263.74
500.88
461.72



Jeffamine D-230
250.55
329.57
258.18
321.79
338.59
242.51
333.55



PACM
440.05
263.58
286.69
303.08
372.51
361.02
650.28



1,3-BAC
76.12
256.54
261.43
303.91
131.72
106.13
162.60



IPDA
163.59
237.80
290.40
468.67
507.07
298.58
459.19



Xylene diamine
176.39
91.36
98.11
149.09
214.12
228.24
141.20



Diethylenetriamine
7.55
145.96
156.02
48.15
395.40
178.75
419.54



Tetraethylenepentamine
129.76
104.91
331.80
103.05
428.99
324.58
472.33










Priamine 1075
PS



1,8 DA Octane
HW





PS—Phase separated


S—Soft, sticky surface


HW—Highly wrinkled













TABLE 25







Reduced elastic modulus (9MPa) of coatings formulated from GLY 23/24, GLY 13/16,


GLY 17 and EPON 828 with amine curatives.












Curing Temperature (° C.)
RT
60
100















Resin
Curing Time
7 Days
1 hr.
3 hr.
7 Days
1 hr.
3 hr.
7 Days












GLY 23/24
TEG-DA (XTJ-504)
PS
















Jeffamine t403
11.2
5.6
9.5
9.3
7.8
8.1
8.3










Jeffamine D-230
S



Jeffamine D-400

















PACM
5.3
5.5
3.4
5.4
3.0
2.2
5.3



1,3-BAC
50.4
45.1
65.8
125.1
38.1
45.4
118.0



IPDA
2.7
303.0
3.3
2.3
4.0
5.1
3.2



Xylene diamine

420.3















Diethylenetriamine
PS



Tetraethylenepentamine




Priamine 1075

















1,8 DA Octane
587.7
122.5
2.7
52.4
11.2
9.5
9.2


GLY 17
Jeffamine t403
4.6
1.2
4.4
4.3
4.7
4.3
5.4


GLY 13/16
Jeffamine t403
5.0
7.1
4.6
5.6
3.4
4.4
5.6



PACM
5.3
5.5
3.4
5.4
3.0
2.2
5.3



1,3-BAC
362.6
310.1
5.2
8.2
5.0
8.8
7.9


EPON 828
TEG-DA (XTJ-504)

189.1
252.8







Jeffamine t403
7.1
4.4
5.1
4.7
4.9
7.3
8.3



Jeffamine D-230
5.9
6.3
5.0
6.2
6.3
4.5
6.5



PACM
9.8
4.5
4.8
4.4
4.9
5.1
10.0



1,3-BAC
1.9
5.0
4.4
3.0
3.7
2.9
3.9



IPDA
4.5
4.5
4.8
6.1
6.8
4.6
6.1



Xylene diamine
3.9
3.3
3.1
12.6
4.4
5.4
4.1



Diethylenetriamine
309.7
2.8
1.8
1.3
5.5
48.6
8.2



Tetraethylenepentamine
3.3
2.4
5.1
2.0
6.4
4.4
8.4










Priamine 1075
PS



1,8 DA Octane
HW





PS—Phase separated


S—Soft, sticky surface


HW—Highly wrinkled





Claims
  • 1. A diol having the following structure:
  • 2. (canceled)
  • 3. (canceled)
  • 4. (canceled)
  • 5. (canceled)
  • 6. (canceled)
  • 7. A method of making a diol of claim 1, comprising, consisting essentially of, or consisting of: reacting 5-hydroxymethyl furfural (HMF), diformyl furan (DFF), or a derivative thereof with a Grignard reagent,under conditions sufficient to form the diol.
  • 8. The method of claim 7, wherein the Grignard reagent is RMgCl, wherein R is H, C1-C6alkyl, C1-C6alkenyl, aryl, or C1-C6alkyl-aryl.
  • 9. (canceled)
  • 10. A diglycidyl ether having the following structure:
  • 11. The diglycidyl ether of claim 10 having the following structure:
  • 12. The diglycidyl ether of claim 11, wherein R2 is methyl or phenyl.
  • 13. The diglycidyl ether of claim 10 having the following structure:
  • 14. The diglycidyl ether of claim 13, wherein R1 and R2 are both methyl, n-butyl, or allyl.
  • 15. The diglycidyl ether of claim 10 having the following structure:
  • 16. A method for making the diglycidyl ether of claim 10, comprising, consisting essentially of, or consisting of: reacting a diol with epichlorohydrin under conditions sufficient to form the diglycidyl ether,wherein the diol has the following structure:
  • 17. The method of claim 16, wherein the diol cannot have the following structure:
  • 18. A curable coating composition comprising, consisting essentially of, or consisting of: a) at least one diglycidyl ether of claim 10; andb) an amine.
  • 19. The curable coating composition of claim 18, wherein the amine is an aliphatic, an aromatic, a cycloaliphatic, or a polyether amine.
  • 20. The curable coating composition of claim 19, wherein the aliphatic amine is Priamine 1075, 1,8-diaminooctane, diethylenetriamine, or tetraethylenepentamine.
  • 21. The curable coating composition of claim 19, wherein the aromatic amine is m-xylylenediamine.
  • 22. The curable coating composition of claim 19, wherein the cycloaliphatic amine is 1,3-bis(aminomethyl)cyclohexane, isophorone diamine, or bis(p-aminocyclohexyl) methane.
  • 23. The curable coating composition of claim 19, wherein the polyether amine is JEFFAMINE EDR-148 (XTJ-504), JEFFAMINE D-400, JEFFAMINE D-230, or JEFFAMINE T-403.
  • 24. (canceled)
  • 25. (canceled)
  • 26. A composite or adhesive comprising, consisting essentially of, or consisting of at least one diglycidyl ether of claim 10.
CROSS-REFERENCE TO RELATED APPLICATION

This application claims priority to U.S. Application No. 62/871,387, filed Jul. 8, 2019, which is incorporated herein by reference.

STATEMENT OF U.S. GOVERNMENT SUPPORT

This invention was made with government support under grant IIA-1355466 awarded by the National Science Foundation. The U.S. government has certain rights in the invention.

PCT Information
Filing Document Filing Date Country Kind
PCT/US2020/040918 7/6/2020 WO
Provisional Applications (1)
Number Date Country
62871387 Jul 2019 US